Financial Disclosure The authors did not report any potential conflicts of interest.
References:
Friedman M, Mor L, Shazar R, Paul N, Kerner R, Keidar R, et al. Treatment of early pregnancy loss with mifepristone and misoprostol compared with misoprostol only. Obstet Gynecol 2025;145:204–9. doi: 10.1097/AOG.0000000000005800
Bartley J, Tong S, Everington D, Baird DT. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception 2000;62:297–303. doi: 10.1016/s0010-7824(00)00187-6
Chien LW, Liu WM, Tzeng CR, Au HK. Effect of previous live birth and prior route of delivery on the outcome of early medical abortion. Obstet Gynecol 2009;113:669–74. doi: 10.1097/AOG.0b013e31819638e6
Gluck O, Barber E, Friedman M, Feldstein O, Tal O, Grinstein E, et al. Failure rate of medical treatment for miscarriage correlated with the difference between gestational age according to last menstrual period and gestational size calculated via ultrasound. J Clin Med 2023;12:6112. doi: 10.3390/jcm12196112